Renal Cancer - Results from #520

Pathogenic Roles for RNASET2 in Clear Cell Renal Cell Carcinoma. March 8, 2024

The Survival Outcomes of the Metastatic Nonclear Cell Renal Cell Carcinoma in the Immunotherapy Era: Princess Margaret Cancer Centre Experience. March 8, 2024

The Impact of Nursing Interventions on the Treatment Outcomes of Renal Cell Carcinoma with Postoperative Interleukin-2 and Recombinant Human Interferon March 7, 2024

Linear Muscle Segmentation for Metastatic Renal Cell Carcinoma: Changes in Clinic-Friendly Estimation Predict Survival Following Cytoreductive Nephrectomy. March 7, 2024

The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data. March 7, 2024

The impact of metastasectomy on survival of patients with synchronous metastatic renal cell cancer in Finland: A nationwide study. March 6, 2024

Advanced Renal Cell Carcinoma With Inferior Vena Cava Thrombus Treated With a Combination of Preoperative Lenvatinib and Pembrolizumab. March 6, 2024

The incidence, pathogenesis, and management of non-clear cell renal cell carcinoma. March 5, 2024

Partial nephrectomy for renal tumors: recommendations of the Italian Society of Urology RCC working group. March 5, 2024

Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial. March 4, 2024

Nurse-led renal cell carcinoma clinic: a single center review. March 4, 2024

Neighborhood social vulnerability and disparities in time to kidney cancer surgical treatment and survival in Arizona. March 1, 2024

Cytokine Signaling in Pediatric Kidney Tumor Cell Lines WT-CLS1, WT-3ab and G-401. March 1, 2024

Survival pattern of metastatic renal cell carcinoma patients according to WHO/ISUP grade: a long-term multi-institutional study. February 29, 2024

A Pooled Analysis of Treatment-Free Survival in Advanced Renal Cell Carcinoma. February 29, 2024

Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiving nivolumab: post-hoc analysis of the Meet-URO 15 study. February 28, 2024

The Impact of a Multidisciplinary Tumor Board (MTB) on Treatment Decision Making for Patients With Renal Cell Carcinoma (RCC): 5-Year Data Analysis. February 28, 2024

Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-Trial. February 27, 2024

Magnetic resonance imaging-guided renal biopsy shows high safety and diagnostic yield: a tertiary cancer center experience. February 27, 2024

First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX-Targeting Peptide, [68Ga]Ga-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma. February 26, 2024

Page 27 of 459